XILIO THERAPEUTICS INC's ticker is and the CUSIP is 98422T100. A total of 32 filers reported holding XILIO THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,441,444 | $1,365,768 | 20.01% |
| Bain Capital Life Sciences Investors, LLC | 3,785,450 | $3,586,714 | 0.39% |
| Rock Springs Capital Management LP | 3,003,259 | $2,845,588 | 0.09% |
| SevenBridge Financial Group, LLC | 41,000 | $37,179 | 0.01% |
| Dunhill Financial, LLC | 10,274 | $9,735 | 0.01% |
| Pinnacle Financial Group, LLC / IL | 10,000 | $9,475 | 0.00% |
| XTX Topco Ltd | 33,289 | $31,541 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 71,081 | $67,349 | 0.00% |
| Avantax Planning Partners, Inc. | 25,000 | $23,688 | 0.00% |
| BlackRock Finance, Inc. | 66,418 | $62,931 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 13,271 | $12,574 | 0.00% |
| ADAR1 Capital Management, LLC | 1,500 | $1,421 | 0.00% |
| JPMORGAN CHASE & CO | 59 | $56 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,207 | $3,988 | 0.00% |
| MORGAN STANLEY | 1,112,740 | $1,054,321 | 0.00% |
| STATE STREET CORP | 43,390 | $41,112 | 0.00% |
| Renaissance Technologies | 295,000 | $279,513 | 0.00% |
| ROYAL BANK OF CANADA | 366 | $0 | 0.00% |
| VANGUARD GROUP INC | 902,531 | $855,148 | 0.00% |
| Qube Research & Technologies Ltd | 4 | $4 | 0.00% |
This page lists XILIO THERAPEUTICS INC's shareholders in Q2 2024. To view XILIO THERAPEUTICS INC's shareholder history, click here.